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ABSTRACT
Although generally regarded as functional in the cytoplasm, a number of microRNAs (miRNAs) have been found in the nucleus,
possibly with a role in gene regulation. Here we report that, in fact, a substantial fraction of all human miRNAs are present in
the nucleus of neural stem cells. Further, subsets of these miRNAs display consistently higher standardized rank in the nucleus
than in the cytoplasm of these cells, as identified with an RT-qPCR technology and confirmed by microarray analysis. Likewise,
other miRNAs display higher cytoplasmic standardized ranks. Three samples were partitioned into nuclear and cytoplasmic
fractions in six assays for 373 miRNAs. From the 100 most highly expressed miRNAs, standard scores of nuclear and cytoplasmic
concentrations were determined. Among those, 21 miRNAs had all three nuclear standard scores higher than all three cytoplasmic
scores; likewise, 31 miRNAs had consistently higher cytoplasmic scores. Random concentrations would result in only five in each
set. Remarkably, if one miRNA has a high standard score in a compartment, then other miRNAs having the same 59 seeds and
certain similar 39 end patterns are also highly scored in the same way. That is, in addition to the seed sequence, 39 sequence
similarity criteria identify families of mature miRNAs with consistently high nuclear or cytoplasmic expression.
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INTRODUCTION
Human miRNAs are a large group (>1000 members) of 16–
27-nt, single-stranded RNA (ssRNA) molecules that are
responsible principally for regulating mRNA translation
and stability (Bartel 2004; Griffiths-Jones et al. 2008; Carthew
and Sontheimer 2009). As presently understood, the biogen-
esis of mature miRNAs originates from large primary tran-
scripts (pri-miRNAs). From the pri-miRNAs, the RNA
binding protein Dgcr8 and the RNase III enzyme Rnasen
recognize and excise precursor stem–loop structures with
44–180 nt creating pre-miRNAs that are then exported to the
cytoplasm. Pre-miRNAs are further processed into the double-
stranded (dsRNA) form of mature miRNAs by a second RNase
III enzyme, Dicer. Cytoplasmic processing is followed by
(or coupled to) assembly of one strand of the miRNA duplex
into a number of multiprotein complexes, all of which con-
tain a member of the miRNA-binding Argonaute protein
superfamily. The assembled complexes bind via base pairing
between the targeted mRNA (typically a subsequence of the
39 UTR) and nucleotides from the 59 end of the miRNA
(often nucleotides 2–8, known as the seed sequence [Lewis
et al. 2005; Grimson et al. 2007]). The Argonaute-containing
complexes inhibit translation or stimulate degradation of
mRNAs to varying degrees, so they are referred to as RNA-
induced silencing complexes (RISCs). A typical mRNA may
have multiple, putative targets for both the same and
different miRNAs, and any particular miRNA may have as
many as hundreds of putative mRNA targets. Hence, given
the substantial number of miRNAs, there presumably exists
a staggering combinatorial network of miRNA-mediated
post-transcriptional gene regulation (Selbach et al. 2008).
On top of the complexities of this network are questions
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about control of controllers, that is, control of biogenesis and
processing of miRNAs, an area of much ongoing research
(Slezak-Prochazka et al. 2010).
While miRNAs generally function in the cytoplasm,
mature miRNAs have been found in the nucleus, and, in
some cases, shown to alter promoter activity (Hwang et al.
2007a; Kim et al. 2008; Marcon et al. 2008; Ohrt et al. 2008;
Place et al. 2008; Foldes-Papp et al. 2009). Other miRNAs
have been localized to the nucleolus (Politz et al. 2009; Liao
et al. 2010) and, notably, the nuclear and nucleolar abun-
dances of some miRNAs have been reported to be greater
than their cytoplasmic levels. As yet there is no complete
molecular understanding for how miRNA subcellular local-
ization is determined. However, siRNAs and piRNAs, mo-
lecular cousins to miRNAs that are produced by somewhat
different processes, also function in the nucleus, e.g., in di-
recting heterochromatin formation in plants, animals, and
fungi, and specifying programmed DNA elimination in
Tetrahymena species (Malone and Hannon 2009; Moazed
2009). Furthermore, exogenously supplied siRNAs can
modify promoter activity in animal cells (Janowski et al.
2006; Li et al. 2006). Argonaute proteins are also found in the
nucleus, and very recent evidence indicates that these pro-
teins function therein in association with siRNAs. In an early
report, Robb and colleagues (Robb et al. 2005) showed
successful RNA interference (knockdown of the noncoding
7SK RNA) in the nucleus of human cells, thereby exciting
interest in synthetic, nuclear control of gene expression. The
means by which Argonaute proteins are imported into
the nucleus is not known but, in some cases, their nuclear
localization has been shown to require binding to siRNAs
(Guang et al. 2008; Aravin et al. 2009). Thus, while Argo-
naute-dependent nuclear import of miRNAs has not been
demonstrated directly, by analogy to siRNA localization,
such a mechanism seems likely. In plants, however, miRNA
biogenesis occurs completely within the nucleus, with the
two sequential RNase III cleavages apparently carried out by
a single Dicer-related enzyme (Voinnet 2009). This suggests
the possibility that some mature miRNAs in animal cells may
be generated in the nucleus, especially since a nuclear pres-
ence for Dicer has not been rigorously excluded (Emmerth
et al. 2010).
In addition to questions as to how miRNAs may become
located in nuclear compartments is the issue of specificity. In
particular, why do some miRNAs show marked propensity to
reside in the nucleus, especially since Argonaute proteins
bind miRNAs and siRNAs independently of sequence. In
this regard, Hwang and colleagues (Hwang et al. 2007a) first
reported that a 6-nt sequence AGUGUU at the 39 end of
human miR-29b is responsible for it being preferentially
localized in the nucleus (71%) compared to nuclear locali-
zation of miR-29a (42%), which lacks the sequence but is
otherwise almost identical. In their supplement, 10 siRNAs
similar to miR-29b were quantified as z30%–70% in the
nucleus. Appending AGUGUU to the 39 ends of other small
ssRNAs was sufficient to cause their nuclear accumulation,
and seven additional sequence motifs promoting the same
have been described in a patent by the same researchers
(Hwang et al. 2007b).
Most of the studies in which mature miRNAs were
observed in animal cell nuclei have employed tumor cells
that have undergone countless passages. Thus, in an effort
to assess the generality of miRNA nuclear localization, the
possible role of sequence dependence, and the influence of
the tumor state on localization, we have analyzed miRNA
distribution in cultured proliferating human neural pro-
genitor cells in passages 4–6 after derivation from human
embryonic stem cells (hESCs). We found that 188 of the 373
assayed mature miRNAs were detected in all experiments in
both the nucleus and cytoplasm, a finding consistent with
a recent report by Liao and colleagues (Liao et al. 2010).
However, among the 100 most strongly detected miRNAs,
a particular set of 21 miRNAs were found to have a consis-
tently high concentration rank in the nucleus; similarly,
another set of 31 miRNAs had a consistently high concen-
tration rank in the cytoplasm (the number in each set ex-
pected to occur by chance is five). Further, compartmental
preference appears to be sequence-specific. Thus, if one miRNA
is preferentially localized, then the other miRNAs having
the same 59 seed sequence and certain similar 39 end patterns
are likewise preferentially localized to the same compart-
ment. Finally, we have developed a particular mathematical




Our interest in the potential role of miRNAs in schizophrenia
(Perkins et al. 2007) prompted us to select human neural stem
cell lines for in vitro experiments. Research into the etiology of
schizophrenia has included neurodevelopmental factors (Lewis
and Levitt 2002). Furthermore, many active research programs
aim to induce pluripotency in differentiated cells, offering the
possibility of deriving neuronal and glial cell cultures from, for
example, somatic cells of schizophrenia patients. Success could
lead to evaluations of diagnostic strategies, the cellular effects of
pharmaceuticals, and indeed fundamental research into the basis
of mental illnesses as complex diseases. These considerations moti-
vated our choice of cell line.
Cells used in our experiments were neural stem cells derived
from human embryonic WA09 cell lines (Aruna Biomedical) as
described by Dhara and colleagues (Dhara et al. 2009). According
to Dhara and Stice (2008) the goals of the provider are optimal
differentiation of human embryonic stem cells (hESCs) to NP cells
and their maintenance as a self-renewing population, available
for further generation of pure populations of specified cell types
in culture. Thus, ArunA has enabled differentiation of hESCs into
NP cells expressing SOX2 and other neuroepithelial markers
(NES, SOX1, SOX3, PSA-NCAM, and MUSASHI-1). Forma-
tion of ‘‘neural rosettes’’ was also reported by ArunA. Additional
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publications describe how the NP cells were derived from hESCs
(Shin et al. 2006, Dhara et al. 2008). The provider certified the cells
in the lot we used to have normal karyotype and consistent DNA
fingerprints.
Cells were cultured according to the manufacturer’s protocol,
except cells were consistently cultured in an atmosphere of low
oxygen (5% O2, 5% CO2, z90% N2) (Panchision 2009). Substrates
were poly-L ornithine-coated and laminin-coated polystyrene plates
in neurobasal medium supplemented with B27 and FGF2 (20 ng/mL).
Cells were passaged at 90% confluence and harvested in linear growth.
Assays were done with cells from passages 4–6.
Since miRNAs are key regulators of stem cell differentiation,
precisely measured miRNA profiles can be expected to change as
neural stem cells differentiate along neuronal or glial lines (Shi
et al. 2010). Assurance that the cells used in this study remained
a relatively homogenous population of neural stem cells across
passages is thus given by analyses of miRNA profiles at each
passage (for details, see Supplement 1).
As fully described in Supplement 1, we performed a nonpara-
metric statistical test that indicated that passage number is not
correlated with results. That is, the two experiments (one nuclear,
one cytoplasmic) associated with any one batch yielded measure-
ments that were not statistically distinguished from the other two
batches. In dramatic contrast, the data of our six experiments were
strongly distinguished by comparing nuclear and cytoplasmic
fractions. These nonparametric tests imply that neither differen-
tiation nor any other confounding factors generated any favorable
or unfavorable bias for any of the three batches of cells in the sense
of altered miRNA profiles.
Focusing further on differentiation, we note that Letzen et al.
(2010) reported extensive miRNA profiles for eight stages of dif-
ferentiation from human embryonic stem cells to terminally dif-
ferentiated oligodendrocytes. Fortuitously, several miRNAs were
assayed in both the Letzen work and in our work. Selected miRNAs
show in Letzen data very dynamic concentration profiles stage-
to-stage, but the same miRNAs in our measurements showed
quantitatively much smaller changes batch-to-batch. Furthermore,
our batch-to-batch changes were qualitatively inconsistent with
stage-to-stage patterns of change. Thus, our batch-to-batch miRNA
changes are both quantitatively and qualitatively inconsistent with
stage-to-stage changes reported by Letzen et al. Full details are in
Supplement 1.
Cell fractionation and RNA isolation
Cytoplasm and nuclear fractions were isolated using a Norgen
Biotek (Thorold) kit following the manufacturer’s instructions.
Cells in a confluent monolayer were washed twice with PBS, and
then ice-cold lysing solution was added. The cells were gently
agitated on ice for 5 min. The lysate was then centrifuged for
10 min at 500 g. The cytoplasmic fraction was selected from the
upper 250 mL and the nuclear fraction from the lower 45 mL,
discarding an intermediate layer of z200 mL with the intention of
controlling cross-contamination. This selection reflected our goal
of obtaining fractions with minimal cross-contamination at the
sacrifice of some quantities of the fractions. RNA was then isolated
from each of the fractions using the supplied buffers and columns.
RNA was vacuum desiccated and then resuspended in RNase free
water to a concentration of z100 ng/mL. Quality and quantity of
total RNA were determined using a NanoDrop ND-1000 Spec-
trophotometer (Thermo Fisher Scientific). Using Agilent 2100
Bioanalyzer DNA and RNA chips, we verified that DNA concen-
tration in the nuclear fraction was >100X that of the cytoplasmic
fraction and that 28S ribosomal RNA peak fluorescence in the
cytoplasmic fraction was >10X that of the nuclear fraction (Sup-
plement 2). These two ratios for the same samples imply good
fractionation.
miRNA RT-qPCR
We used z1000 ng total RNA for reverse transcriptions enabled
by Megaplex RT Primers from Applied Biosystems, followed
by real-time amplification using TaqMan Low Density Array
(TaqMan) hydrolysis probes in v2.0 Pool A 384-well plates, ac-
cording to the manufacturer’s instructions. Megaplex RT Primers
are highly multiplexed RT primers that convert miRNAs in a pool
of 377 types (plus controls) to cDNA, after which the cDNA is
amplified by a 40-cycle reaction. The TaqMan MicroRNA Arrays
v2.0 and Megaplex Primer Pools enable amplification by a second
40-cycle reaction in an Applied Biosystems 7900HT qPCR in-
strument recording position-encoded dye concentration measure-
ments. The output expression profile was keyed with entries in
Sanger miRBase, updated to v14 (Griffiths-Jones et al. 2008).
Supplement 3 correlates the TaqMan list to Sanger miRBase 14;
four miRNA sequences have been recently delisted from previ-
ous Sanger releases, leaving 373 distinct probes for recognized
miRNAs in TaqMan Pool A plates. (None of the delisted miRNA
sequences previously known as miR-672, -674, -871, -872 was
detected in any experiment.) Amplification and analysis were
performed using SDS 2.2 software resulting in data displayed
in Supplement 4. The SDS setting used was always ‘‘Automatic
Baseline,’’ per the manufacturer’s recommendation; however,
the ‘‘Default’’ setting yielded similar final conclusions (data not
shown). A complete account of our background program to validate
the accuracy and reproducibility of TaqMan technology is in
Supplement 5.
Data normalization with standard scores
A standard score is the dimensionless quantity defined by
subtracting the mean from the raw score, then dividing by the
standard deviation. If all raw scores were multiplied by a positive
constant, the resulting standard scores would be unchanged.
Depending upon cell type and state, the ratio of cytoplasm mass
to nucleoplasm mass might vary substantially, so comparison of
measurements of one set of miRNA levels across cell compart-
ments, types, and states might best be performed with standard
scores. With these facts in mind, we decided to rank miRNAs
among multiple samples of nucleoplasm and cytoplasm with
standard scores.
Three samples from confluent cell cultures were first parti-
tioned into nuclear and cytoplasmic fractions, and then assayed
for miRNA Cq values. Each of six experimental sets of Cq values
was standardized by subtracting the mean of the 100 strongest
miRNAs within the experiment and then dividing by the standard
deviation. This standard score has the advantage of not requiring
precise knowledge of the proportion of miRNA molecules
successfully extracted from the nucleus or cytoplasm; that is, both
mean and standard deviation are simple multiples of that pro-
portion, so in the quotient, the standardized score is the same as
would be that of 100% of the molecules. As will be shown in the
Nuclear miRNAs and cytoplasmic miRNAs
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following, this approach allows reproducible detection of small
but consistent differences in miRNA populations. Of course care
must be taken to control cross-contamination.
An miRNA was defined to have dominance in the nuclear
fraction provided all three nuclear standard scores (derived from
raw Cq values among 100 miRNAs) were greater than all three
cytoplasmic standard scores; cytoplasmic dominance was defined
analogously. Among the 100 most highly expressed miRNAs, 21
miRNAs displayed consistently higher standard scores in the
nucleus than in the cytoplasm, and 31 miRNAs displayed consis-
tently higher cytoplasmic standard scores. Both frequencies were
much greater than expected by chance. In 100 simulations of 100
random assignments of six ranked labels into 20 such bins (three
high and three low; see Supplement 6), the very greatest of all
10,000 bin occupancies was 13, attained five times. It can be shown
that the probability of finding 21 or more nuclear dominant as-
signments from 100 sets of six random rankings is 2.08 3 108 and
that for finding 31 or more cytoplasmic dominant assignments
is 1.01 3 1016 (Supplement 6). Hence, nonparametric analysis
implies the above patterns of nuclear and cytoplasmic dominance
cannot be credibly explained as chance events.
In each of the six tests, Cq values were recorded as well as the
plate’s average of its four RNU6 values. Undetected miRNAs had
Cq = 40. Cq values of miRNA species in nuclear and cytoplasmic
fractions were not directly comparable because the initial cellular
volumes of the two fractions were not precisely known. However,
in all six experiments (designated Nuci for nuclear fraction i and
Cytj for cytoplasmic fraction j) the mean, raw Cq values were
nearly the same (range = 32.13–34.30 for [in increasing order]
Nuc2, Cyt2, Cyt1, Cyt3, Nuc1, Nuc3). We averaged the raw
expressed values for each miRNA and chose the 100 miRNAs most
strongly expressed (lowest Cq averages) for further analysis. The
Cq values for the selected 100 miRNAs were all moderately or
strongly detected with raw Cq values <28.
We then derived 100 miRNA standard scores for each of the six
experiments. By definition, standard scores for one experiment
have mean = 0 and standard deviation (SD) = 1. Standard scores
across all six plates had a global range from 2.81 (mean of six
lowest = 2.67, SD = 0.09) to +1.96 (mean = 1.80, SD = 0.15).
Thus, all six plates had consistent distributions. The Grubb test
(Barnett and Lewis 1994) was used to check for outliers, and none
was detected.
The standard scores of 14 of the 100 strongest miRNAs had
t-test P-values < 0.05, but only one survived correction for multi-
ple testing (P < 0.05/100). Therefore quantitative evaluation of
individual miRNAs could not be informative. Nonparametric
methods were developed.
Rankings of concentrations of miRNAs in nucleus
or in cytoplasm
Three samples from confluent cell cultures were first partitioned
into nuclear and cytoplasmic fractions, and then assayed for
miRNA Cq values. Using global, raw Cq values, the 100 strongest
miRNAs were selected. Each of six experimental sets of Cq values
was normalized by subtracting the mean within the experiment
and then dividing by the standard deviation, yielding standard
scores. A miRNA was defined to be preferentially ranked in the
nuclear fraction provided all three nuclear standard scores were
stronger than all three cytoplasmic standard scores; preferential
cytoplasmic ranking was defined analogously. Among the 100
most highly expressed miRNAs, 21 miRNAs displayed consistently
stronger (lower) standard scores in the nucleus, and 31 miRNAs
displayed consistently stronger standard scores in the cytoplasm;
both frequencies were much greater bin occupancies than ex-
pected by chance, as noted previously.
Of the 373 miRNAs, we detected 188 (Cq < 40) in all six ex-
periments; 162 were strongly or moderately detected (Cq < 35) in all
six experiments; and 260 were detected both in at least one nuclear
sample and in at least one cytoplasmic sample (Supplement 4).
Regarding sensitivity and specificity of our experiments, we
note results for six members of the let-7 family tested in the plate
and designated let-7a, -b, -c, -d, -e, -g. As mature miRNA se-
quences, these are similar in that, mature let-7a, -b, -c sequences
differ by only one or two bases, and the maximum number of
different bases across all 15 pairs is four. None of these six let-7
miRNAs was strongly expressed in any of our samples, but all were
detected in all samples with exactly one exception, let-7a in Nuc3.
We found that the six-dimensional let-7 vectors had high Pearson
correlations over the 15 possible pairs from the six samples; Pearson
correlations ranged from 0.84 to 0.99 with mean = 0.93 and SD =
0.06 (Supplement 5 contains complete data). If each of the six
measurements were random in the sense of some arbitrary base
measurement plus some uniformly random value in an arbitrary
range, then the Pearson correlations would be expected to populate
the interval [1, 1] with expected average zero. The observed
Pearson correlations imply the let-7 probes are specific and,
considering their consistent patterns of detection of weak expres-
sion, sensitive. These observations are in concordance with exten-
sive tests of TaqMan hydrolysis probes reported by Chen and
colleagues (Chen et al. 2005).
Verification of PCR results with a microarray
Cells from one additional batch were partitioned as in the above-
mentioned experiments into nuclear and cytoplasmic fractions,
and each fraction was subdivided into three technical replicates.
All replicates were adjusted to a concentration of z28–30 ng/mL
of small RNAs. A sample of 5 mL of each replicate was applied to
six Agilent miRNA microarrays. The Agilent microarrays provided
probes for 15 of the miRNAs in the TaqMan nuclear list (of 21);
there were probes for 21 miRNAs in the TaqMan cytoplasmic list
(of 31). Hence, there were 36 common miRNA probes in the
TaqMan distinguished lists and in the inventory tested by the
Agilent microarray.
Quality control parameters were satisfactory in all six Agilent
microarrays (data not shown). Our statistical analysis used the
log2 value of the ‘‘gTotalGeneSignal’’ from the Agilent text output
(Supplement 7), called herein ‘‘log transformed values.’’ All 36 of
the miRNAs assayed by the Agilent product and also distinguished
in TaqMan experiments were detected in all six microarrays. The
values for the 36 probes over all six microarrays ranged from 2.06
to 12.64 (Supplement 7).
Only one of the log transformed values of the 36 common
miRNAs had a t-test P-value < 0.05, but none survived correction
for multiple testing (P < 0.05/36). Therefore, quantitative evalu-
ation of miRNAs individually could not be informative. Non-
parametric methods were developed.
The global median of log transformed values for the 36 probes
in nuclear samples was 0.36 less than the global median for the
Jeffries et al.
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cytoplasmic samples. After adding that difference to nuclear
sample median values, for each of the 36 miRNAs, a revised nuclear
median was compared to a cytoplasmic median. We found that of
the 15 TaqMan nuclear list probes represented in Agilent, 11 had
higher nuclear medians. We found that of the 21 TaqMan
cytoplasmic probes represented in Agilent, 14 had higher cytoplas-
mic medians. The probability of seeing the above nuclear result
or better (11 or more of the 15 possible) by chance is 0.06. The
probability of seeing the cytoplasmic result or better (14 or more of
the 21 possible) by chance is 0.09. Thus, the chance probability of
seeing both at least 11 of the TaqMan nuclear probes and at least 14
of the TaqMan cytoplasmic probes consistently distinguished by
Agilent medians of log transformed values is 0.0056.
In all of the aforementioned Agilent assay analyses, the median
can be replaced by the average. The analogous calculation shows
that of the 15 TaqMan nuclear list probes represented in Agilent,
nine had higher nuclear medians. Likewise, of the 21 TaqMan
cytoplasmic probes represented in Agilent, 15 had higher cyto-
plasmic medians. The probability of such a chance alignment or
better of TaqMan and Agilent results is 0.0119.
We conclude that, though microarray results are not as dramatic
as the TaqMan results, microarray results do confirm that our
TaqMan nuclear and cytoplasmic lists of dominant miRNAs were
unlikely to have risen by chance.
Cytoplasm ClustalW2 (Larkin et al. 2007) employs a dynamic
programming method that first scores alignments of small subsets
of sequences, then merges larger and larger subsets with superior
local scores to declare an overall alignment. ClustalW2 has numer-
ous parameters that can be tuned, as befits a heuristic solution
to a complex problem that can seldom be precisely defined by
the user.
ClustalW2 yields a set of alignments that is a deterministic
consequence of sequence input and parameter selection, identify-
ing common bases in certain positions in aligned sequences.
Importantly, there is further information in the ClustalW2 output,
namely, in the order of sequences in the output. That is, if se-
quences A, B, and C appear in the order A, then B, then C, then A
is at least as similar in the ClustalW2 sense to B as to C and
possibly more so. This additional information is exploited in our
miRNA Sequence Family Alignments.
There are numerous mathematical definitions of sequence
families. Nonetheless we propose yet another algorithm because
it is especially appropriate for emphasis of miRNA sequence
similarity both in seed region and in the terminal 39 bases. Of
course other reasonable tests of exact or nearly exact seed identity
and at least moderate 39 similarity could be devised to organize
the miRNA sequences in the context of the logic explained below
(see Box 1). Indeed, enhancements that allow more complex tests
might better define miRNA sequence families; the version below is
merely a straightforward example.
We have found the following algorithm to predict many cases
of sequence families that are consistently in the nuclear or
cytoplasmic concentration columns as shown in Table 1.
In other words, two miRNA sequences X and Y are in one
sequence family if they have identical seed regions and if in the
ClustalW2 alignment of the artificial 17-base sequences formed
from them, they appear consecutively with very similar 39 ends.
Specifically, comparing the last consecutive eight bases of X down
to Y and the last eight consecutive bases of Y up to X, they must
exhibit at least five identical base matches.
Given our definition of sequence family, for the 373 distinct
mature miRNA sequences in the intersection of Applied Bio-
systems TaqMan Pool A and Sanger release 16 of September 2010,
there are 100 miRNAs in 43 sequence families of sizes 2–8. Se-
quence families include the familiar examples of the family miR-
17-93 = {miR-17, -20a, -20b, -93, -106a, -106b} and a family of
seven let-7 miRNAs together with miR-98.
RESULTS
miRNAs in neural stem cells
We chose to determine the subcellular distribution of
miRNAs in human embryonic neural progenitor stem cells.
The cells are commercially available with rigorous and well-
described quality control procedures (Dhara et al. 2009).
Cells were harvested while in linear growth, and lysates were
quickly partitioned into nuclear and cytoplasmic fractions
with a Norgen Biotek system. Good fractionation was
BOX 1. miRNA Sequence Family Algorithm testing 59 and 39 similarity
1. For each mature miRNA delete the terminal 59 base, then concatenate the remaining seven 59 end bases with the last 10 39 end bases,
making an artificial sequence of length 17.
2. Use ClustalW2 (command line version for >500 sequences) to align the sequences using default field values.
3. If the first seven bases of two consecutive sequences as aligned by ClustalW2 are not identical, then the corresponding miRNAs are not in
a sequence family.
4. Else, compute a ‘‘match down’’ score for sequence X followed immediately by sequence Y as follows. For the last eight bases of X (not
counting  [gap] entries in X in the ClustalW2 alignment), assign a summand of +1 if a base in X is identical to the corresponding base in
Y; if the Y base does not match or if the Y value is negative, then assign a summand 1. If the total of summands is <2, then the
corresponding miRNAs are not in a sequence family.
5. Else, compute a ‘‘match up’’ score for sequence Y preceded immediately by sequence X as follows. For the last eight bases of Y (not
counting  entries in Y in the ClustalW2 alignment), assign a summand of +1 if a base in Y is identical to the corresponding base in X; if the
X base does not match or if the X value is negative, then assign a summand1. If the total of summands is <2, then the corresponding miRNAs
are not in a sequence family.
6. Else, the two consecutive sequences correspond to miRNAs that are in the same sequence family.
7. Finally, if X and Y are in a sequence family and Y and Z are in a sequence family, then so are X and Z, allowing sequence families with
multiple members.
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confirmed by use of DNA chips and RNA chips in an Agilent
2100 Bioanalyzer (Supplement 2). Total RNA from both
fractions was analyzed by an Applied Biosystems RT-qPCR
assay configured to yield quantification cycle measurements
(Cq values) for a set of 373 mature miRNAs. In total, the
analysis was carried out using cells grown in three separate
batches, that is, six assays of 373 mature miRNAs.
No biochemical protocol is likely to result in perfect
nuclear/cytoplasmic fractionation, but perfect or even nearly
perfect subcellular separation is not required in our non-
parametric, bin occupancy analysis. That is, nonparametric
analysis of our data leads to strong conclusions about relative
rankings of mature miRNAs that would only be weakened by
cross-contamination. The strongest 100 miRNA profiles
were selected from the six experiments. Over each experi-
ment, those Cq values were normalized by conversion to
standard scores, thus having mean = 0 and SD = 1. This
reduces the risk of bias from generally stronger signals in one
experiment versus another.
An miRNA was defined to have nuclear dominance if all its
three nuclear standard scores were higher than all three
cytoplasmic standard scores; in an analogous manner we
defined instances cytoplasmic dominance. This is, in effect,
a comparison of ranks of levels of an miRNA in nucleus
versus ranks of the same miRNA levels in cytoplasm. There
are 6!/(3!33!) = 20 ways to assign three nuclear measure-
ments and three cytoplasmic measurements into two bins
of three below and above the median. Of the 20 possible
assignments, one has all three nuclear standard scores less
than (stronger than) all three cytoplasmic standard scores,
and another has all three cytoplasmic standard scores less
than all three nuclear standard scores. We refer to these
two assignments as dominance of an miRNA in nucleus or
cytoplasm. The null hypothesis would be consistent with
expecting five of the 100 miRNAs in each of 20 bins including
the two bins of nuclear or cytoplasmic dominance.
As shown in Figure 1, the assignments into bins from our
data are quite different from this random expectation. The
miRNAs with nuclear or cytoplasmic dominance are shown
in Table 1 (complete data in Supplement 4). It is important to
note that we expect five of the entries of each type to be
present by chance. Allowing such chance membership is how
TABLE 1. The miRNAs in human neural progenitor cells that are
distinguished by nuclear or cytoplasmic concentration as in Figure 1
21 Concentrated in N 31 Concentrated in C
miRNA Rank of 100 miRNA Rank of 100
miR-16 4 miR-106a 1
miR-30c 10 miR-17 2
miR-19a 13 miR-20a 5
miR-30b 19 miR-20b 6
miR-331-3p 20 miR-93 7
miR-342-3p 23 miR-26a 18
miR-345 26 miR-21 24
miR-320 28 miR-130a 27
miR-186 29 miR-18a 32
miR-374b 30 miR-15b 35
miR-140-5p 33 miR-301b 36
miR-28-3p 41 miR-125b 39
miR-590-5p 50 miR-221 40
miR-374a 52 miR-135a 42
miR-598 55 miR-103 43
miR-197 58 miR-100 44
miR-339-3p 59 miR-25 45
miR-193b 61 miR-99a 46
miR-335 62 miR-744 47
miR-210 63 miR-532-5p 56











The miRNAs were selected from the 100 most strongly expressed
miRNAs among 373 tested (Supplement 4). If nuclear and cyto-
plasmic levels were random, then five would be expected by
chance in each of the two columns. We note that the average rank
of the nuclear miRNAs is 38 (expect with random ranks 50.5),
whereas that for cytoplasmic miRNAs is 48 (expect 50.5). Further,
the number of nuclear miRNAs in the top 10 is two (expect from
random data 2.1) and of cytoplasmic mIRNAs is five (expect 3.1).
Among the top 20s we see five nuclear miRNAs (expect 4.2) and
six cytoplasmic miRNAs (expect 6.2). Thus, rank is not obviously
correlated with nuclear or cytoplasmic preference.
FIGURE 1. A pattern of differential miRNA concentration from an
assignment of our 100 most strongly expressed miRNAs into 20 bins.
Each bin corresponds to an ordering by standard scores of three nuclear
samples and three cytoplasmic samples, relative to measurements of all 100
miRNAs in each experiment. The far left bin has a count of 21 miRNAs
with all three nuclear rankings stronger than all three cytoplasmic rankings.
The far right bin has a count of 31 miRNAs with all three cytoplasmic
rankings stronger than all three nuclear rankings. If miRNAs were not
biased to preferential concentration in nuclear or cytoplasmic fractions,
then the expected occupancy of each of the 20 bins would be five. Cross-
contamination of sample types would generally weaken distinguishing bin
allocations; the extraordinary allocations here are in spite of—not caused
by—any imperfections of nuclear/cytoplasmic partitioning. It can be
shown that the probability of finding 21 or more preferential assignments
from 100 sets of six random rankings is 2.083108 and that for finding
31 or more is 1.0131016 (Supplement 6).
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nonparametric analysis of the collective
informativeness of a set of miRNAs can
be meaningful. By contrast, t-test P-values
from the same miRNA data do not imply
significance of any individual miRNA.
Sequence relationships among
top ranking miRNAs
Having identified particular miRNAs
with compartmental dominance of stan-
dard scores, we next asked whether these
miRNAs shared sequence similarity. Al-
though there are numerous mathemati-
cal definitions for families of similar
sequences, we proceeded to develop an
algorithm that emphasizes miRNA se-
quence similarity based upon seed region
and the terminal 39 bases. For shared
membership in a sequence family, the
algorithm first requires that the seven-
base seeds of two miRNA sequences be
identical. Second, it requires that in a cer-
tain alignment of two sequences; of the
last eight bases of one, at least five should
match consecutive bases within the last 10
bases of the other. By focusing alignment
on the two ends of a mature miRNA, this
approach is a simple application of the
principle of correspondence, that is, gen-
eral alignment of RNAs with focus on
blocks of residues (Brown et al. 2009). As
described below, our experimental data
imply that miRNAs having identical seeds
and similar 39 regions tend to have either
entirely nuclear dominance or entirely
cytoplasmic dominance (Table 2).
We also made use of a relaxation of the
requirement that all three nuclear stan-
dard scores be strictly less than (or strictly
greater than) all three cytoplasmic stan-
dard scores. That is, the two sets of values
could have minimal overlap, so the lowest
of the high bin is lower than the highest of
the low bin by a small amount relative
to the standard deviations = 1. Then
an miRNA might be defined to be weakly nuclear if sub-
tracting a small constant from all three of the nuclear
standard scores leaves three nuclear values consistently
below the adjusted median for all six values; relaxed cyto-
plasmic comparisons can be analogously defined. The gaps
(minimum of upper minus maximum of lower) between
the three high and the three low sets of standard scores for
the 21 + 31 = 52 most highly ranked miRNAs have average
z 0.141 and SD z 0.122. In that context, we can select a
typical overlap for relaxed normalized values of miRNAs to be
something less than 0.100 = one-tenth of 1 SD for the sample.
For example, in Table 2 the notation ‘‘0.046/C’’ for miR-106b
means that the consequence of subtracting 0.046 from the
three cytoplasmic standard scores leaves consistently lower
(stronger) cytoplasmic standard scores. Interestingly, miR-
106b is the only miRNA in the conventional miR-17-93
sequence family (as defined by Mendell [2008]) that does not
display cytoplasmic dominance without relaxation and also
TABLE 2. Sets of miRNA sequences determined both by the Sequence Family Algorithm
(defined in the following) applied to miRBase (Griffiths-Jones et al. 2008) sequences
and by membership among the 100 most strongly expressed miRNAs in our experiments
The first base of the mature miRNA sequence has been omitted to emphasize seed identities.
The shown sequence families include at least one nuclear or cytoplasmic miRNA with
preferential localization. Ten such sequence families exist from our tests and nine, with
relaxation in some cases, are completely nuclear (blue) or completely cytoplasmic (orange).
Nuclear miRNAs and cytoplasmic miRNAs
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is the only one with a significantly different 39 end that
precludes membership in the same sequence family as
defined herein. Regarding verification, we assayed three
technical replicates of the nuclear fraction of one sample
versus three technical replicates of the cytoplasmic fraction of
the same sample using six miRNA microarrays on one
Agilent slide. Focus was on the 36 miRNAs that are both
included as Agilent assays and included among the 52
miRNAs distinguished by the TaqMan experiments. Pearson
correlations among the 36 nuclear and cytoplasmic replicates
averaged z0.983 and z0.991, respectively (Supplement 7).
However, the nine cross-compartment Pearson correlations
averaged z0.988, that is, slightly better than correlations
among the three nuclear technical replicates; this reflects the
close similarities of the nuclear and cytoplasmic signatures
relative to the accuracy available with the Agilent micro-
arrays. The implication is that parametric analysis of mea-
surements for individual miRNAs cannot be informative.
Nonparametric tests that identify collectively informative
sets of miRNAs are essential. As noted previouisly, non-
parametric methods provided validation using median
standard score data (P = 0.0056 for chance consistency) or
average data (P = 0.0119 for chance consistency). Other
miRNAs are not in the top 100, but otherwise do conform to
the rule that if one in a sequence family has nuclear or
cytoplasmic dominance, then all in the sequence family have
the same dominance (Supplement 8).
It should be noted that declaring sequence families is
always heuristic and that experimentation with various
settings of tunable parameters can lead to different align-
ments and so to different sequence families. Furthermore,
even with the same settings, selecting subsets of a pool can
revise pairwise alignments. However, our experiments es-
tablish the general principle that a combination of 59 and
39 alignments can yield sequence families that are correctly
predicted to be mostly or entirely miRNAs with nuclear
dominance or mostly or entirely miRNAs with cytoplasmic
dominance. In contrast, two mature miRNAs with the same
seed but very different 39 ends do not typically exhibit
correlated rankings or, in experiments of others, correlations
of other types.
In contrast with sequence families, we may consider
physical clusters. Of the 52 listed miRNAs, miR-342-3p and
miR-345 are in a physical cluster and both exhibit nuclear
dominance. Likewise the six-member miR-363-106a phys-
ical cluster includes three miRNAs (miR-106a, -18b, -20b)
with cytoplasmic dominance and the others with no dom-
inance. However, in the six-member miR-17-92-1 physical
cluster are three with high cytoplasmic ranking, but one
(miR19a) with a high nuclear ranking. Strangely, although
miR-28-3p and miR-219-5p have higher than average
nuclear ranking, their partners, miR-28-5p and miR-219-
2-3p, show higher cytoplasmic ranking. And although
miR-16-2 and miR-15b are in a physical cluster, miR-16
shows nuclear preference, whereas miR-15b shows cyto-
plasmic. Thus, there appear to be no simple rules that bias
miRNAs in a physical cluster to share nuclear or cytoplas-
mic dominance.
Sequences that have identical seeds but are not
members of one sequence family
Aside from the sequence families that are consistently highly
ranked in the nucleus or cytoplasm in Table 2, we note two
other pairs. Some miRNAs have identical seeds but fail to match
strongly by the two-ended test of our miRNA Sequence Family
Algorithm (Box 1). Consider the four miRNAs in Table 3.
Here miR-15a, -15b, -16, and -195 all share the same seed
AGCAGCA, but the first two are in one sequence family and
the last two are in another (Supplement 8). The first two have
stronger cytoplasmic standard scores but the last two do not
(Supplement 4). Likewise miR-21 and miR-590-5p have iden-
tical seeds but do not belong to one sequence family and do not
display the same compartment dominance (see Table 4).
Thus, seed identity in itself is not sufficient to predict
membership in a sequence family of miRNAs with shared
nuclear or cytoplasmic dominance.
Regarding the three human miRNAs with seed AGCACCA,
Hwang and colleagues (Hwang et al. 2007a) found that miR-
29b in HeLa cells was preferentially located in the nucleus
(71% nuclear), miR-29a was predominantly cytoplasmic
(58%), and miR-29c was not detectable. Over base positions
2–17 from the 59 end these miRNAs are nearly identical, but
in the 39 ends, miR-29b is markedly different. Interestingly, the
above-mentioned miRNA Sequence Family Algorithm (Box
1) declares that miR-29a and miR-29c are in a sequence family
of two, excluding miR-29b (Table 5; Supplement 8).
We, too, have studied the apparent role of . . .AGUGUU in
miR-29b in HeLa cells (Jeffries et al. 2009), finding that indeed
that AGUGUU associates with nuclear import. However, in
our present experiments using human neural progenitors,
miR-29b was only weakly detected, and miR-29a, -c were not
clearly biased to nuclear or cytoplasmic dominance.
Motif ASUS in 39 ends of miRNAs
As noted in the Introduction, Hwang, Wentzel, and Mendell
further found that other small ssRNAs, when modified to
include, like miR-29b, the sequence . . .AGUGUU at their
39 termini, could also accumulate in the nucleus. This was
reflected in a patent listing UGUGUU, ACUGUU, AGAGUU,
TABLE 3. Four miRNAs with identical seeds and with 39 ends
(last 10 bases) that cluster into two subsets according to our
Sequence Family Algorithm
miRNA Mature sequence Rank Dominance
miR-15a UAGCAGCACAUAAUGGUUUGUG 106 cytoplasm
miR-15b UAGCAGCACAUCAUGGUUUACA 35 cytoplasm
miR-16 UAGCAGCACGUAAAUAUUGGCG 4 none
miR-195 UAGCAGCACAGAAAUAUUGGC 81 none
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AGUCUU, AGUGAU, AGUGUA, AGNGUN (Hwang et al.
2007b); notably ASUS (S = C or G) appeared in six of the eight
(underlined) motifs. This observation prompted us to look
for ASUS in the 39 regions of the 21 miRNAs that displayed
stronger nuclear standard scores and in the 31 with stronger
cytoplasmic standard scores. Of the 21 in the nuclear list, seven
included ASUS in the last nine bases (recall five of the 21 were
expected to be in the list by chance). From the 39 ends of the
seven with stronger nuclear ranking in our experiments, we
found instances of ASUS as underlined in Table 6.
Although official tables usually show one miRNA se-
quence for one miRNA label, often there are actually multiple
mature miRNA subtypes with different ends, as can be de-
tected with deep sequencing (Liao et al. 2010). The 39 end is
particularly variable, possibly relevant to the variable posi-
tions of ASUS in these examples. Among the 31 miRNAs that
consistently display stronger cytoplasmic standard scores, no
mature sequences include ASUS in the last nine bases. Thus, we
speculate some role for ASUS in bringing about higher than
average levels of miRNA nuclear localization.
Additional relevance to earlier work
Regarding other work in the same area, we note a report
by Lakshmipathy and colleagues (Lakshmipathy et al. 2007)
that compared miRNA expression in undifferentiated ver-
sus differentiated hESCs. Testing hESCs, differentiated cells,
and terminally differentiated adult cells, they found some
miRNAs that decrease sharply with hESC differentiation
(e.g., miR-371, -372, -302a, -302d) and others that increase
(let-7a, miR-143, -29a). This pioneering work suggested
miRNAs and also their mRNA targets transcribed from
pluripotency genes could serve as signatures of stages of stem
cell differentiation.
Laurent and colleagues (Laurent et al. 2008) reported
miRNA signatures for a variety of stem cell and differentiated
cell types. Among miRNAs distinguished by high expres-
sion levels in hESCs were many with seeds AAAGAGC or
AAGGUGC, such as some members of the miR-17-92
physical cluster (physically close miRNAs on chromosome
13). Wilson and colleagues (Wilson et al. 2009) used miRNA
microarrays to compare miRNA signatures of human-in-
duced pluripotent stem cells (hiPSCs) versus hESCs. They
found statistically significant differences between the two cell
types, evidenced in expression of some physical clusters such
as miR-17-92 and the miR-302 cluster.
Chin and colleagues (Chin et al. 2009)
compared 15 hiPSC lines, 12 hESC lines,
and three fibroblast lines. They reported
that gene expression profiles of hiPSCs
showed a recurrent signature distin-
guished from that of hESCs, regardless
of somatic source. The hiPSC expression
signatures became, upon extended pas-
saging, progressively similar to but al-
ways distinct from those of hESCs. As evident in early
passages, hiPSCs seemed to be incompletely reset to hESC
expression patterns. Regarding gene expression, hiPSCs rela-
tive to hESCs generally favored genes associated with differ-
entiation at the expense of genes associated with basic pro-
cesses, such as energy production, nucleic acid processing,
and mitosis. Using an miRNA bioarray (Zhang et al. 2008)
they showed that several miRNAs serve as signatures of types
and stages of stem cell differentiation.
DISCUSSION
A number of reports have described the occurrence of
particular miRNAs in animal cell nuclei and nucleoli (Hwang
et al. 2007a; Kim et al. 2008; Marcon et al. 2008; Ohrt et al.
2008; Place et al. 2008; Foldes-Papp et al. 2009; Politz et al.
2009; Liao et al. 2010). In this article, we wished to evaluate
the generality of miRNA nuclear localization by assaying
a nontumor, minimally passaged, progenitor cell line.
Our experiments have established that in a human neural
progenitor cell line, several miRNAs have consistently
stronger standard scores in nuclear fractions than in cyto-
plasmic fractions. Likewise, other miRNAs have stronger
cytoplasmic standard scores, and about half of all strongly
expressed miRNAs have no clear preference. Nonparametric
statistical analyses convincingly established that the obser-
vations cannot be ascribed to chance. The mature sequences
of miRNAs with the first base omitted can be organized
according to their identity among their seeds and a certain
similarity among bases at the 39 ends. Interestingly, if one
member of a sequence family displays consistently stronger
standard scores among the 100 most strongly expressed
miRNAs in nucleus or cytoplasm, then the others show the
same compartmental ranking.
In addition to a higher than average nuclear or cytoplasmic
ranking for particular miRNAs, our study also confirms with
an alternative technology the finding of Liao and colleagues
(Liao et al. 2010) that the majority of all miRNAs are present
not only in the cytoplasm, as expected, but in the nucleus as
well. However, there are important differences between our
results and those of Liao et al. First, the miRNAs, identified by
Liao and colleagues, as being over-represented in the nucleus
were different from those that we identified. However,
Liao et al. examined a nasopharyngeal carcinoma cell line,
whereas we used neural progenitor cells. Perhaps differ-
ences in distinguished lists may be related to cell type or to
TABLE 4. Two miRNAs with identical seeds that do not belong to one sequence family
and do not display the same compartment dominance
miRNA Mature sequence Rank Dominance
miR-21 UAGCUUAUCAGACUGAUGUUGA 24 cytoplasm
miR-590-5p GAGCUUAUUCAUAAAAGUGCAG 50 nucleus
Nuclear miRNAs and cytoplasmic miRNAs
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the untransformed versus tumor state of cells; indeed, such
differences may be useful biomarkers. Second, Liao and
colleagues used one sequencing experiment, each, for nucleus
and cytoplasm; we have used three biological replicates. Third,
Liao and colleagues use Illumina sequencing validated with
a microarray, while we used TaqMan assays, also validated
with a microarray. Importantly, Willenbrock and colleagues
(Willenbrock et al. 2009) reported that Exiqon and Agilent
miRNA microarray expression measures correlate better with
synthetic miRNA-like spikes than expression measures ob-
tained from sequencing data and that the two technologies
perform equivalently in terms of reproducibility and relative
ratio quantification. The same performance would likely
be expected of the miRNA microarray used by Liao et al.
(Tang et al. 2007). Notably, our microarray experience with
two triplets of technical replicates resulted in data much
noisier than that from TaqMan assays of triple biological
replicates. Fourth, we have explored a motif associated with
miRNAs displaying a high nuclear ranking preference, i.e.,
ASUS in the 39 end of mature miRNAs; this motif includes
the sequence AGUGUU previously found to be associated
with nuclear localization of miR-29b (Hwang et al. 2007a,
Jeffries et al. 2009) and is allowed in six of the eight patterns in
a patent (Hwang et al. 2007b).
Although the cytoplasmic functions of miRNAs are well
established, what might be the role for miRNAs in the nu-
cleus, especially the subsets showing a higher than average
nuclear prevalence? Two human miRNAs, miR-373 and
miR-320, have been reported to regulate the activities of
specific promoters, the former inducing and the latter
repressing transcription (Kim et al. 2008; Place et al. 2008).
These findings establish a potential nuclear role for miRNAs,
and, although bioinformatic analyses suggest that many
more miRNAs might target promoter regions (Kim et al.
2008), the generality of miRNA-mediated transcriptional
regulation is yet to be established directly. Interestingly, our
present study revealed a nuclear preference for the afore-
mentioned miR-320.
Alternatively, return of some miRNAs to the nucleus
might be simply a way to sequester them from the cytoplasm
and fine-tune their impact on translational regulation and
mRNA stability. If so, the particular distribution of miRNAs
across the nuclear envelope could be a useful signature of,
e.g., the state of cell division, differentiation, or response to
stress. Failure to regulate miRNA nuclear versus cytoplas-
mic distribution could conceivably contribute to cellular
pathology.
Other connections to gene regulation are suggested by
findings reported by Smalheiser and colleagues (Smalheiser
and Torvik 2006). The sequence GCACUU in the Alu con-
sensus is predicted to be a hairpin loop, so it might be
available for targeting by several miRNAs that include
AAGUGC in their seeds, such as the miR-17-93 sequence
family, miR-302a(b,c,d,e), miR-372, miR-373, miR-519a,
b-3p, c-3p, d, miR-520a-3p, b, c-3p, d-3p, and e. This list
strongly intersects lists of miRNAs distinguishing stem cells
by other researchers (Laurent et al. 2008; Chin et al. 2009;
Wilson et al. 2009). However, what mechanistic role the
cytoplasm-preferring miR-17-93 physical sequence family or
the other families play in stem cell phenomena remains to be
discovered.
Similarly, one might ask what genes are mutually targeted
by the nucleus-preferring miR-30b, c, miR-19a, b, and miR-
374a, b sequence families (Table 2). Given mRNA targets for
these miRNAs as suggested by TargetScan 5.1 (Lewis et al.
2005; Friedman et al. 2009), the search engine DAVID
(Dennis et al. 2003; Huang da et al. 2009) declares 33 genes
potentially targeted by all of them. The list includes genes for
proteins known to be active in the nucleus, in neurodevelop-
ment, and in DNA-dependent transcription regulation in-
cluding ELL2, HLF, MECP2, MEF2D, NEUROD1, NFIB,
NRK, SATB1, and SOX4. These intriguing findings point to
potential avenues of research.
Complementing the above findings for miR-373 and miR-
320, Younger and Corey (2009) reported that siRNAs in human
cells can target noncoding RNAs (ncRNAs) that overlap pro-
moters and coding sequences, often affecting expression of the
coding gene and suggesting a similar regulatory role for
endogenous miRNAs. At least in the case of miRNAs displaying
a nuclear preference, their corresponding targets may not be
annotated mRNAs, but as yet unannotated ncRNAs for which
miRNA base-pairing rules may differ from those that apply to
miRNA–mRNA interactions in the cytoplasm. The conserva-
tion of 39 motifs we find associated with miRNAs showing
a nuclear preference may be a reflection of such alternative
rules.
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TABLE 5. The Sequence Family Algorithm declares that miR-29a




TABLE 6. The pattern ASUS appears in 39 ends of seven miRNAs
with stronger nuclear ranking in our experiments
miR-30b . . .ACUCAGCU
miR-30c . . .ACUCUCAGC
miR-19a . . .ACUGA
miR-374a . . .AGUG
miR-374b . . .AGUG
miR-590-5p . . .AGUGCAG
miR-193b . . .AGUCCCGCU
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